CAR-T

News

Jun 07, 2016 06:00 AM EDT

Chimeric Antigen Receptor T-Cell (CAR-T) Therapies Set To Gain Approval By 2017

A new kind of therapy aimed at addressing an immune system’s powerful T-cells could be out as early as next year if two pharmaceutical companies regulatory approval gains ground.

CAR-T

News

Chimeric Antigen Receptor T-Cell (CAR-T) Therapies Set To Gain Approval By 2017

More on SCIENCEWR

Understanding and Limiting Cross-Reactivity in ELISA Testing

6 Ways to Stamp Out Employee Burnout

Ferrari Energy Describes How the Oil and Gas Industries are Refueling Reinvention

The Effects Of Coronavirus On Sleep: How To Get A Good Night's Rest

The Relationship Between Sleep Deprivation And Work Performance

The Biggest Data Breaches in 2021 and How You can Protect your Company’s Data

Color Contact Lenses - Get new eye color contact lenses and look beautiful

Watch Out for These Red Flags When Picking a VPN as an Expat

Life Changing: Benefits Of Having Whiter Teeth

4 Features You Need in a Medical Translation Agency

What Role Does AI Play in Healthcare?

Most Read on SCIENCEWR

Spotlight

Lasers That Learn: Embracing The Digital Age

Smart Circle Jobs: Defining the Employee Landscape of a Marketing Powerhouse

First Steps After Dementia Diagnosis

The Year in Review: Five Incredible innovations that Rocked the World in 2021

5 Breakthrough Technologies

Russian Arctic Researchers Say: Norilsk Fish Safe to Eat

Can You Purchase an Auto Extended Warranty For a Subaru?

RegMedNet Explains How CAR-T Therapy Can Engineer Patients’ Immune Cells to Treat Their Cancers

How To Promote Mental Health in the Workplace